Mercator Medical S.A.

WSE:MRC Voorraadrapport

Marktkapitalisatie: zł515.9m

Mercator Medical Inkomsten in het verleden

Verleden criteriumcontroles 0/6

Mercator Medical's earnings have been declining at an average annual rate of -32.6%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been declining at an average rate of 11.3% per year.

Belangrijke informatie

-32.6%

Groei van de winst

-32.7%

Groei van de winst per aandeel

Medical Equipment Groei van de industrie25.3%
Inkomstengroei-11.3%
Rendement op eigen vermogen-0.5%
Nettomarge-0.5%
Volgende winstupdate29 Nov 2024

Recente prestatie-updates uit het verleden

Mercator Medical's (WSE:MRC) Solid Earnings Have Been Accounted For Conservatively

Jun 06
Mercator Medical's (WSE:MRC) Solid Earnings Have Been Accounted For Conservatively

Recent updates

Improved Revenues Required Before Mercator Medical S.A. (WSE:MRC) Stock's 31% Jump Looks Justified

Aug 22
Improved Revenues Required Before Mercator Medical S.A. (WSE:MRC) Stock's 31% Jump Looks Justified

Mercator Medical's (WSE:MRC) Solid Earnings Have Been Accounted For Conservatively

Jun 06
Mercator Medical's (WSE:MRC) Solid Earnings Have Been Accounted For Conservatively

Returns At Mercator Medical (WSE:MRC) Are On The Way Up

Sep 23
Returns At Mercator Medical (WSE:MRC) Are On The Way Up

Should You Be Adding Mercator Medical (WSE:MRC) To Your Watchlist Today?

Nov 06
Should You Be Adding Mercator Medical (WSE:MRC) To Your Watchlist Today?

Is Now The Time To Put Mercator Medical (WSE:MRC) On Your Watchlist?

Jul 13
Is Now The Time To Put Mercator Medical (WSE:MRC) On Your Watchlist?

Mercator Medical's (WSE:MRC) Promising Earnings May Rest On Soft Foundations

May 19
Mercator Medical's (WSE:MRC) Promising Earnings May Rest On Soft Foundations

What Kind Of Shareholders Hold The Majority In Mercator Medical S.A.'s (WSE:MRC) Shares?

Dec 23
What Kind Of Shareholders Hold The Majority In Mercator Medical S.A.'s (WSE:MRC) Shares?

Opbrengsten en kosten

Hoe Mercator Medical geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

WSE:MRC Opbrengsten, kosten en inkomsten (PLN Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Jun 24489-21210
31 Mar 2448791230
31 Dec 23469-201270
30 Sep 23470-2321290
30 Jun 23491-1941410
31 Mar 23519-2141440
31 Dec 22543-1901450
30 Sep 22704201530
30 Jun 22926411490
31 Mar 221,3141671480
31 Dec 211,7294471480
30 Sep 212,1037891360
30 Jun 212,3341,1021330
31 Mar 212,1851,1951270
31 Dec 201,8359301170
30 Sep 201,3195831070
30 Jun 20872230950
31 Mar 2062123880
31 Dec 19540-2840
30 Sep 19534-1810
30 Jun 195010760
31 Mar 19452-1710
31 Dec 184208650
30 Sep 183649580
30 Jun 1833010520
31 Mar 1831610460
31 Dec 173015430
30 Sep 172925410
30 Jun 172848400
31 Mar 1727811400
31 Dec 1626414380
30 Sep 1625914370
30 Jun 1625411370
31 Mar 1623810350
31 Dec 1522710340
30 Sep 1521111310
30 Jun 1519312290
31 Mar 1518112270
31 Dec 1416810250
30 Sep 141608240
30 Jun 141547230
31 Mar 141516210
31 Dec 131487210

Kwaliteitswinsten: MRC is currently unprofitable.

Groeiende winstmarge: MRC is currently unprofitable.


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: MRC is unprofitable, and losses have increased over the past 5 years at a rate of 32.6% per year.

Versnelling van de groei: Unable to compare MRC's earnings growth over the past year to its 5-year average as it is currently unprofitable

Winst versus industrie: MRC is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.7%).


Rendement op eigen vermogen

Hoge ROE: MRC has a negative Return on Equity (-0.53%), as it is currently unprofitable.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden